{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:49:12Z","timestamp":1791143352092,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ejca.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T11:15:51Z","timestamp":1299842151000},"page":"1013-1020","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic value of survivin expression in parotid gland cancer in consideration of different histological subtypes"],"prefix":"10.1016","volume":"47","author":[{"given":"Markus","family":"Stenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Demgensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Molls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Luers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grosheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian U.","family":"Huebbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Klussmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2011.02.005_b0005","unstructured":"Barnes L, Eveson JW, Reichart P, Sidransky D. Tumours of the salivary gland. In: Pathology and genetics. Head and neck tumours. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2005: p. 209\u201381."},{"key":"10.1016\/j.ejca.2011.02.005_b0010","series-title":"Salivary gland carcinoma \u2013 stepping up the prognostic ladder","author":"Vander Poorten","year":"2002"},{"key":"10.1016\/j.ejca.2011.02.005_b0015","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1158\/1055-9965.EPI-09-0638","article-title":"Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States","volume":"18","author":"Boukheris","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2011.02.005_b0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/14737140.8.4.645","article-title":"Salivary gland cancers: current treatments, molecular characteristics and new therapies","volume":"8","author":"Chandana","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejca.2011.02.005_b0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/030089160909500406","article-title":"Surgery and radiotherapy in the treatment of malignant parotid tumors: a retrospective multicenter study","volume":"95","author":"Nagliati","year":"2009","journal-title":"Tumori"},{"key":"10.1016\/j.ejca.2011.02.005_b0030","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hed.20830","article-title":"Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer","volume":"30","author":"Hamakawa","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2011.02.005_b0035","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","article-title":"Systemic therapy in the palliative management of advanced salivary gland cancers","volume":"24","author":"Laurie","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.02.005_b0040","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/cncr.24015","article-title":"Prognostic index for patients with parotid carcinoma: international external validation in a Belgian\u2013German database","volume":"115","author":"Poorten","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2011.02.005_b0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/02841860500543208","article-title":"Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases","volume":"45","author":"Luukkaa","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2011.02.005_b0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-213X-1-5","article-title":"Developmental expression of survivin during embryonic submandibular salivary gland development","volume":"1","author":"Jaskoll","year":"2001","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.ejca.2011.02.005_b0055","first-page":"4845","article-title":"Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides","volume":"60","author":"Schmitz","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2011.02.005_b0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s007950100017","article-title":"The role of survivin as a new target of diagnosis and treatment in human cancer","volume":"34","author":"Yamamoto","year":"2001","journal-title":"Med Electron Microsc"},{"key":"10.1016\/j.ejca.2011.02.005_b0065","first-page":"18","article-title":"Expression and clinic pathological significance of survivin mRNA and protein in salivary gland tumors","volume":"16","author":"Qi","year":"2007","journal-title":"Shanghai Kou Qiang Yi Xue"},{"key":"10.1016\/j.ejca.2011.02.005_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2011.02.005_b0075","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1038\/sj.onc.1207113","article-title":"Survivin, versatile modulation of cell division and apoptosis in cancer","volume":"22","author":"Altieri","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2011.02.005_b0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jcp.10327","article-title":"Survivin study: what is the next wave?","volume":"197","author":"Li","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejca.2011.02.005_b0085","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.tripleo.2008.12.054","article-title":"The oncogenic effects of constitutive STAT3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac","volume":"107","author":"Nikitakis","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ejca.2011.02.005_b0090","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.tripleo.2008.12.052","article-title":"Immunohistochemical expression of the oncogenic molecules active STAT3 and survivin in benign and malignant salivary gland tumors","volume":"107","author":"Nikitakis","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ejca.2011.02.005_b0095","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bjc.6604192","article-title":"Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer","volume":"98","author":"Preuss","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2011.02.005_b0100","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/sj.bjc.6601402","article-title":"Survivin expression in oral squamous cell carcinoma","volume":"89","author":"Lo","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2011.02.005_b0105","first-page":"55","article-title":"Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors","volume":"55","author":"Giefing","year":"2008","journal-title":"Neoplasma"},{"key":"10.1016\/j.ejca.2011.02.005_b0110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/ajot.2001.28068","article-title":"Primary squamous cell carcinoma of the parotid gland","volume":"22","author":"Lee","year":"2001","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.ejca.2011.02.005_b0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0030-4220(90)90271-S","article-title":"Undifferentiated carcinomas of the major salivary glands","volume":"69","author":"Hui","year":"1990","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.ejca.2011.02.005_b0120","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00000421-198612000-00009","article-title":"Malignant parotid tumors. Prognostic factors and optimum treatment","volume":"9","author":"Theriault","year":"1986","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.02.005_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0385-8146(03)00096-8","article-title":"Clinicopathological study of undifferentiated carcinoma of the parotid gland","volume":"30","author":"Hatta","year":"2003","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.ejca.2011.02.005_b0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hed.21071","article-title":"Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings","volume":"31","author":"Khan","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2011.02.005_b0135","first-page":"182","article-title":"Major salivary gland diseases. Multicentre study","volume":"25","author":"Fiorella","year":"2005","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.ejca.2011.02.005_b0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.oraloncology.2006.03.001","article-title":"Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients","volume":"43","author":"Rapidis","year":"2007","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2011.02.005_b0145","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/hed.20876","article-title":"Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma","volume":"30","author":"Preuss","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2011.02.005_b0150","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/onc.2008.303","article-title":"New wirings in the survivin networks","volume":"27","author":"Altieri","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2011.02.005_b0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-1702(02)00190-9","article-title":"Human papillomavirus immortalization and transformation functions","volume":"89","author":"Munger","year":"2002","journal-title":"Virus Res"},{"key":"10.1016\/j.ejca.2011.02.005_b0160","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hed.10128","article-title":"Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region","volume":"24","author":"Hauser","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2011.02.005_b0165","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1600-0463.2009.02512.x","article-title":"Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma","volume":"117","author":"Lee","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.ejca.2011.02.005_b0170","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.leukres.2009.09.003","article-title":"Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells","volume":"34","author":"Ito","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2011.02.005_b0175","doi-asserted-by":"crossref","unstructured":"Zhang X, Yue P, Fletcher S, et al. A novel small-molecule disrupts STAT3 SH2 domain-phosphotyrosine interactions and STAT3-dependent tumor processes. Biochem Pharmacol 2010.","DOI":"10.1016\/j.bcp.2010.01.001"},{"key":"10.1016\/j.ejca.2011.02.005_b0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2867-9-25","article-title":"Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signaling","volume":"9","author":"Chesnokov","year":"2009","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ejca.2011.02.005_b0185","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1535-7163.MCT-05-0436","article-title":"Targeted therapy by disabling crossroad signaling networks: the survivin paradigm","volume":"5","author":"Altieri","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejca.2011.02.005_b0190","first-page":"905","article-title":"Enhancement of apoptosis in salivary gland cancer cells by the combination of oral fluoropyrimidine anticancer agent (S-1) and radiation","volume":"25","author":"Harada","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejca.2011.02.005_b0195","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hed.20652","article-title":"Antibody responses to survivin and their clinical significance in patients with head and neck cancer","volume":"29","author":"Eto","year":"2007","journal-title":"Head Neck"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T06:24:13Z","timestamp":1560061453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804911000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0959804911000888"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2011.02.005","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}